Cargando…
Rational engineering of adeno‐associated virus capsid enhances human hepatocyte tropism and reduces immunogenicity
OBJECTIVES: Gene therapy based on recombinant adeno‐associated viral (rAAV) vectors has been proved to be clinically effective for genetic diseases. However, there are still some limitations, including possible safety concerns for high dose delivery and a decreasing number of target patients caused...
Autores principales: | Han, Jiabao, Zhu, Liyu, Zhang, Jingwen, Guo, Lu, Sun, Xuehan, Huang, Cheng, Xu, Kai, Zhang, Ying, Li, Wei, Zhou, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715358/ https://www.ncbi.nlm.nih.gov/pubmed/36135100 http://dx.doi.org/10.1111/cpr.13339 |
Ejemplares similares
-
Directed evolution of adeno-associated virus 5 capsid enables specific liver tropism
por: Wang, Yuqiu, et al.
Publicado: (2022) -
Coevolution of Adeno-associated Virus Capsid Antigenicity and Tropism through a Structure-Guided Approach
por: Havlik, L. Patrick, et al.
Publicado: (2020) -
Improving clinical efficacy of adeno associated vectors by rational capsid bioengineering
por: Sen, Dwaipayan
Publicado: (2014) -
Modifying immune responses to adeno-associated virus vectors by capsid engineering
por: Bentler, Martin, et al.
Publicado: (2023) -
The Role of the Adeno-Associated Virus Capsid in Gene Transfer
por: Van Vliet, Kim M., et al.
Publicado: (2008)